The 200 doesn't care about FA per se - it just tells you about what buyers are doing and the longer term trend shifting - once it closes above and then holds it it's usually more a case of could'a should'a would'a ...
But the FA seems to match the trend - a pretty hot tech licensed out of a top university, in a super hot space with plenty of large deals of late even on pre-clinical assets, recently shored up funding so that's secured, 2 ultra's in the registry, Roche / Genentech being the number 1 cancer drug provider in the world - i doubt you get their ex VP development & CMO a long with their head of partnering, business development because they thought a change of scenery with something flimsy and a tiny biotech "down under" was a logical next step. Not to forget the CEO sold Chemgenex to Cephalon for a few hundred million.
- Forums
- ASX - By Stock
- Ann: First patent granted for Deoxymab-nanoparticles
The 200 doesn't care about FA per se - it just tells you about...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1283356 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 4958674 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1283356 | 0.006 |
12 | 4399891 | 0.005 |
8 | 5414000 | 0.004 |
5 | 5899016 | 0.003 |
1 | 2520000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 4958674 | 5 |
0.008 | 1521890 | 4 |
0.009 | 1040280 | 4 |
0.010 | 355230 | 3 |
0.012 | 1292407 | 3 |
Last trade - 16.12pm 27/09/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
Day chart unavailable